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Individual Differences in Anterior Cingulate Activation
Associated with Attentional Bias Predict Cocaine Use After
Treatment
Reshmi Marhe1, Maartje Luijten1,2, Ben JM van de Wetering3, Marion Smits2 and Ingmar HA Franken*,1,4
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Drug-dependent patients often relapse into drug use after treatment. Behavioral studies show that enhanced attentional bias to drug
cues is a precursor of relapse. The present functional magnetic resonance imaging (fMRI) study examined whether brain regions involved
in attentional bias are predictive of cocaine use after treatment. Attentional bias-related brain activity was measured—with a cocaine
Stroop task—in cocaine-dependent patients during their first week in detoxification treatment and was used to predict cocaine use at
3-month follow-up. The predictive value of attentional bias-related brain activity in a priori defined regions of interest, in addition to other
measures such as self-reports of substance severity, craving, and behavioral attentional bias were examined. The results show that craving
in the week before treatment and individual variability in attentional bias-related activity in the dorsal anterior cingulate cortex (dACC)
were significant predictors of days of cocaine use at 3-month follow-up and accounted for 45% in explained variance. Brain activity in the
dACC uniquely contributed 22% of explained variance to the prediction model. These findings suggest that hyperactive attentional bias-
related brain activity in the dACC might be a biomarker of relapse vulnerability as early as in the first week of detoxification treatment.
Ultimately, this may help to develop individually tailored treatment interventions to reduce relapse risk.
Neuropsychopharmacology (2013) 38, 1085–1093; doi:10.1038/npp.2013.7; published online 30 January 2013
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INTRODUCTION
The main goal of most substance dependence treatment is
to prevent patients from relapsing into substance use.
Despite the efforts to treat substance-dependent patients
effectively, treatment dropout rates are generally450% and
most patients subsequently relapse (Miller, 1996; Franken
and Hendriks, 1999; Ha¨ttenschwiler et al, 2000). The
identification of predictors of substance use relapse have
been of high interest in addiction research (eg, Miller et al,
1996; Donovan, 1996; McKay, 1999). Particularly in cocaine
addiction, a variety of predictors of relapse have been tested
including demographic variables, substance use severity,
and craving (for a review, see Poling et al, 2007). These
predictors are largely based on self-report measures.
However, over the years the idea that addiction is a
relapsing brain disorder (Leshner, 1997) has gained more
interest. Support for this idea comes from recent studies
suggesting that (neuro)cognitive measures might be better
predictors of relapse than self-report measures (Marissen
et al, 2006; Kosten et al, 2006). Currently, addiction research
is focusing more on the role of cognitive predictors in
relapse to substance use, and specifically the neural
correlates of cognitive control (Garavan and Hester, 2007;
Goldstein and Volkow, 2011).
Attentional bias is one of the most studied cognitive
processes in addiction. Attentional bias in addiction refers
to the automatically enhanced cognitive processing of drug-
related (salient) stimuli compared with neutral (non-
salient) stimuli. Recent theories suggest that it is associated
with craving and therefore has an important role in the
maintenance and relapse of drug dependency (Franken,
2003; Field and Cox, 2008). A widely used task to measure
attentional bias is the addiction Stroop task (Cox et al,
2006). Behavioral studies that have used the addiction
Stroop paradigm in substance-dependent individuals have
indeed found an attentional bias toward the substance of
abuse (for a review, see Cox et al, 2006). More importantly,
several studies show that attentional bias to substance-
related stimuli (on the behavioral level) is a predictor of
treatment outcome and relapse in smoking (Waters et al,
2003; Powell et al, 2010), alcohol (Cox et al, 2002, 2007),
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heroin (Marissen et al, 2006), and cocaine use (Carpenter
et al, 2006; Marhe et al, 2012). These results indicate a
possible clinical relevance of attentional bias. In addition,
more recent studies have taken an interest in studying the
neural substrates of attentional bias in addiction.
Brain regions that have been found to be associated with
attentional bias in addiction include (prefrontal) cortices
such as the anterior cingulate cortex (ACC; Luijten et al,
2011, 2012; Nestor et al, 2011; Vollsta¨dt-Klein et al, 2012),
dorsolateral prefrontal cortex (DLPFC; Hester and Garavan,
2009; Luijten et al, 2012; Vollsta¨dt-Klein et al, 2012), insula
(Luijten et al, 2011; Vollsta¨dt-Klein et al, 2012), and
subcortical structures such as the nucleus accumbens
(Nestor et al, 2011) and amygdala (Vollsta¨dt-Klein et al,
2012; Janes et al, 2010a). Most pertinent to the present study
is that attentional bias-related brain activity in the insula
and dorsal ACC (dACC) has been found to be predictive of
smoking relapse (Janes et al, 2010b). Involvement of the
ACC in response to cocaine cues has also been found in a
study with cocaine users (using the addiction Stroop task;
Goldstein et al, 2009). However, no study to date has
examined whether brain regions involved in attentional bias
to cocaine stimuli (as measured by a Stroop task) are
predictive of cocaine relapse after treatment.
The goal of the present study therefore was to examine
whether brain activity during a cocaine Stroop task
measured in the first week of detoxification treatment
would be associated with cocaine use measured at 3-month
follow-up. Based on aforementioned studies, we hypothe-
sized that brain regions involved in attentional bias (ie,
dACC, DLPFC, insula, nucleus accumbens, and amygdala)
would be associated with cocaine use at follow-up.
MATERIALS AND METHODS
Participants
Participants were 34 cocaine-dependent inpatients recruited
from an addiction treatment center (Bouman-GGZ) in
Rotterdam, the Netherlands. Inclusion criteria were (1) age
between 18 and 65 years; (2) DSM-IV diagnosis for cocaine
dependence (assessed by both a physician and a research
psychologist); and (3) the ability to speak, read, and write in
Dutch at an eighth-grade literacy level. Exclusion criteria
were (1) indications of severe psychopathology (ie, psy-
chosis and severe mood disorder, as assessed by a
physician); (2) self-reported color blindness or (non-
corrected) defective vision; (3) pregnancy or breast-feeding;
and (4) functional magnetic resonance imaging (fMRI)
contra-indications. We had to exclude the data of eight
participants. Reasons for exclusion were loss to follow-up
(n¼ 1); mismatch between self-reported days of cocaine use
and urine results at follow-up (n¼ 1); vision problems
(n¼ 2); an accuracy rate on the Stroop task ofo60% (n¼ 3;
these participants also showed excessive head motion of
43mm); major anatomical abnormality observed on MRI
(n¼ 1). The final sample consisted of 26 cocaine-dependent
patients (for demographics, see Table 1).
Approval of the study was received from the Ethics
Committee of the Erasmus MC—University Medical Center
Rotterdam, Rotterdam, the Netherlands. All procedures
were carried out with the adequate understanding and
written informed consent of the participants. All partici-
pants received a financial compensation of 35 euros after
completion of the fMRI measure and 25 euros after
completion of the 3-month follow-up measure. The present
study was part of a larger study that investigated relapse
using other psychophysiological and cognitive measures
(not reported in the present study).
Stroop Task
A cocaine Stroop task was used to measure attentional bias
for cocaine-related stimuli. The task contained 10 cocaine
words (Dutch equivalent of basepipe, crack, smoke, cocaine,
blow, line, coke, snort, powder, and base), 10 neutral words
drawn from the category ‘indoor features’ (Dutch equivalent
of blanket, sofa, oven, lamp, attic, cabinet, armchair, tap,
couch, and stove), and 10 letter strings (eg, MMMM; Waters
et al, 2012). Letter strings were included to increase the
number of conditions in the task which, in combination
with a semi-random block order, reduced multicollinearity
between parameter estimates for cocaine and neutral words
(see Supplementary Information, Part I for more informa-
tion on the order of task conditions). Words and letter
strings were presented in the colors blue, yellow, green, or
red. Participants were instructed that they should ignore the
meaning of the word and only respond to the color that the
word was presented in. They were instructed to indicate as
rapidly and accurately as possible in which color the word
was presented by pressing one of four response buttons
with corresponding colors.
Table 1 Demographic and Substance Use Variablesa
Subject variable Final sample
(n¼ 26)
Demographic variables
Age 38.7 (9.2)
Males (%) 85
Education (%)
Primary education 4
Junior secondary education 54
Senior secondary education 31
Higher education 11
Substance use variables
Total years of cocaine use 11.4 (6.3)
Number of days of cocaine use in 30 days before
treatment entry
16.5 (11.9)
Cocaine administration route (%)
Snorting 31
Smoking 65
Intravenous 4
Craving in the week before treatment
OCDUS desire and control (1–5) 2.8 (1.1)
Abbreviation: OCDUS, Obsessive Compulsive Drug Use Scale.
aValues are means (SD) unless otherwise indicated (%).
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The task started with 32 practice trials consisting of only
letter strings. Next, in the experimental phase, stimuli were
presented in a blocked design with three categories
(cocaine, neutral, and letter strings). Every category was
presented six times, resulting in a total of 18 blocks. Each
block contained 10 words. After each six blocks, there was
a 38-s resting period. Order of presentation of the task
conditions was semi-random; block order was the same
for each participant. Each experimental trial began with a
250-ms fixation cross, followed by stimulus presentation
with a duration of 1750ms. Response could be given within
this timeframe. After response, the stimulus remained on
screen. No feedback regarding performance accuracy was
provided to the participants.
Procedure
Patients entered the treatment center for an inpatient
detoxification treatment. A standard detoxification treat-
ment in this setting has a duration of 3 weeks. The specific
goal of this treatment is to reduce cocaine withdrawal
symptoms by means of psychoeducation about the detox
symptoms and individual therapy based on cognitive-
behavioral techniques. Afterwards, the patients start a
follow-up treatment at a different department within the
same treatment center. This is usually a rehabilitation
program with a variable duration between 1 month and 2
years, depending on the need for treatment.
Patients that met the study criteria were informed about
the study on the second day of their detoxification
treatment. They had 24 h to decide whether to participate.
Volunteers signed the informed consent on the third day of
detoxification treatment. Cocaine use severity was assessed
using the Addiction Severity Index (ASI; McLellan et al,
1980; Hendriks et al, 1989) and past week craving using the
cocaine version of the Obsessive Compulsive Drug Use Scale
(OCDUS; Franken et al, 2002). On the fourth day of
treatment, participants were escorted to the Erasmus
Medical Center where they performed the cocaine Stroop
task in the scanner. After completion, participants were
escorted back to the treatment center.
To ensure retention and compliance for the follow-up
assessment, the researcher first collected multiple contact
information at the start of the study. For example, we
collected phone numbers and e-mail addresses of the
participant but also of their family, friends, social workers,
and other professionals involved with the patient. Second,
the participant was informed that (s)he would receive a
financial compensation of 25 euros for completion of the
follow-up assessment. Third, participants were ensured that
information on current use (both self-reports and urine
screens) was used for research purposes only. Participants
were contacted 3 months after study participation via
telephone and/or e-mail to set up an appointment for a face-
to-face follow-up interview. Follow-up tests were performed
in the treatment center. If a participant was out of treatment
at this point, then he/she was asked to return once to the
treatment center to complete the follow-up tests. If the
participant was unable to travel to the main treatment
center for the assessment, then the researcher would
perform the assessment in the (for the participant) nearest
Bouman-GGZ treatment facility. If that was also not
possible, then we arranged transfer by taxi for the
participant to the treatment center.
Outcome Measure
The number of days of recent cocaine use was measured
3 months after study participation. At follow-up, partici-
pants were asked to report the number of days they had
used cocaine in the last 30 days, which we labeled ‘recent
cocaine use’. Self-reports were biochemically verified by
means of urine screens. All self-reports of 0 days of use in
the last 30 days were confirmed by a negative urine screen,
except for one participant who reported 0 days of use while
the urine screen was positive. This participant was excluded
from the analysis (see Participants section). In the final
sample, 11 participants reported not to have used cocaine in
the last month and 15 participants reported to have used
cocaine 12.1 days on average (range 1–30, SD 10.6) in the
last month.
fMRI Data Acquisition and Processing
Imaging data were obtained with a 3T GE Healthcare MRI
scanner. Blood oxygen level-dependent (BOLD) sensitive
functional echo-planar imaging T2*-weighted images were
acquired in 34 axial slices (thickness¼ 2.6mm, interslice
gap¼ 0.4mm) covering the entire supratentorial brain with
a repetition time (TR) of 2500ms, echo time (TE) of 30ms,
field of view (FOV) of 220mm, and matrix size of 64 64.
A structural 3-dimensional inversion recovery (IR) fast
spoiled gradient recalled echo (FSPGR) T1-weighted image
was acquired in 192 axial slices (thickness¼ 1.6 and 0.8mm
overlap, resulting in an effective slice thickness of 0.8mm)
with TR of 12.0ms, TE of 3.7ms, a rectangular FOV of
250 175mm2, and matrix size of 416 256mm. Due to an
unexpected scanner shutdown, we were forced to continue
the project on a different 3T scanner by the same vendor
(GE Healthcare, Milwaukee, WI, USA) during the study.
Data of n¼ 8 were acquired on the Signa HDxt scanner and
data of n¼ 18 were acquired on the Discovery MR750
scanner. In Supplementary Information (Part VII), we
describe additional analyses regarding the use of two
scanners. There we report temporal signal-to-noise maps
of both scanners and we conducted the main statistical
analyses with scanner type included as covariate, showing
that it is unlikely that the use of two scanners influenced the
present findings.
Functional images were analyzed using SPM8 (Statistical
Parametric Mapping; Wellcome Trust Centre for Neuroima-
ging, London, UK). Preprocessing of the functional data
included realignment and unwarping of all functional
images. Next, the anatomical scan was co-registered to the
mean T2*-weighted image and subsequently segmented into
gray and white matter. Segmentation parameters were used
for normalization using the SPM T1 MNI 512 template.
Normalized images were spatially smoothed with an 8-mm
full-width at half-maximum Gaussian filter. The three task
conditions, cocaine words, neutral words, and letters were
modeled in the context of the general linear model, using
delta functions convolved with a canonical hemodynamic
response function (error rates were not associated
with activation estimates, see Supplementary Information,
Attentional bias-related brain activity and cocaine relapse
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Part IV for results). The contrast reflecting brain activation
associated with attentional bias (cocaine words minus
neutral words) was calculated for each individual. Subse-
quently, five a priori regions of interest (ROIs) were selected
based on their presumed role in attentional bias, including
the bilateral dACC, DLPFC, insula, nucleus accumbens, and
amygdala (Figure 1; see Introduction section for rationale).
ROIs for the DLPFC, insula, and amygdala were derived
from the automatic anatomical labeling (AAL) atlas
(Tzourio-Mazoyer et al, 2002). Since the dACC and nucleus
accumbens are not included in the AAL atlas, an 8-mm
sphere around MNI coordinates ±8 30 32 was used as an
ROI for the dACC (Mars et al, 2005) and an 8-mm sphere
around MNI coordinates ±10 12  2 was used for the
nucleus accumbens (Knutson et al, 2008). To test the main
attentional bias effect in the ROIs, the cocaine minus neutral
words contrast was entered in a random effects one-sample
t-test. Results were thresholded at po0.05, Family Wise
Error (FWE) corrected for multiple comparisons across the
search volume (small volume correction: Friston et al, 1996;
Worsley et al, 1996). To do so, analyses were first
thresholded at po0.001 uncorrected with 20 contingently
activated voxels (160mm3; see Supplementary Information,
Part V), and then corrected using a small volume correction
(po0.05 FWE corrected) in which the search volume was
restricted by the a priori defined ROIs.
Statistical Analyses
First, to demonstrate attentional bias on a behavioral level
for cocaine words, behavioral data of the Stroop task were
examined (means are displayed in Table 2). Differences in
reaction times (RTs) and accuracy scores for the cocaine
words and the neutral words were tested using a paired
samples t-test. To use the Stroop effect as a predictor in
regression models (described below), a single differential
score was calculated for RT and for accuracy (by subtract-
ing results on cocaine words from neutral words).
Second, linear regression analysis was used to examine
the predictive value of multiple variables (ie, addiction
severity, craving, behavioral and brain-related attentional
bias) in the prediction of the outcome measure ‘recent
cocaine use’. Due to the relative large amount of predictor
variables, a stepwise regression analysis was performed
(Field, 2009). The stepwise method tests, at each addition of
a variable into the regression model, which variable
contributes the least to the prediction of recent cocaine
use and removes this variable from the model. By using this
method all redundant predictors are filtered out of the
model. Because we were interested in the unique contribu-
tion of three clusters of variables (ie, self-reports, behavior,
and imaging) we performed the regression analysis in three
steps. Step 1 contained four self-report variables: total years
of cocaine use, number of days of cocaine use in 30 days
before treatment entry, and cocaine administration route
(ie, addiction severity) as well as craving in the week before
treatment. Since cocaine administration route is a catego-
rical variable with three levels, two dummy variables were
created. Step 2 contained two variables of behavioral data:
Stroop effect RT and Stroop effect accuracy. Step 3
contained the imaging variables (extracted contrast values
for cocaine minus neutral words in the five bilateral ROIs;
left and right dACC, left and right DLPFC, left and right
insula, left and right nucleus accumbens, left and right
amygdala). In each step, the selection criteria for inclusion
and exclusion of predictors in the model were Fenter: pp0.05
and Fremove: pX0.10.
Third, we wanted to check the robustness of the
individual predictors that were included in the model based
on the results of the stepwise regression. To do so,
bootstrapping was used with 2000 bootstrapped samples
and a 95% confidence interval (CI; Efron and Tibshirani,
1993; Mooney and Duval, 1993). The bootstrap procedure
Figure 1 A priori defined, literature-based regions of interest involved in attentional bias to substance cues. dACC, dorsal anterior cingulate cortex;
DLPFC, dorsolateral prefrontal cortex; NACC, nucleus accumbens.
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can only be conducted when predictor variables are forcedly
entered into the regression model (instead of stepwise).
Therefore, predictors that met the inclusion criteria of the
stepwise method were entered in a hierarchical regression
analysis.
Finally, predictors were checked for multicollinearity by
means of tolerance statistics. All statistical analysis were
conducted with SPSS 18.0 (IBM Corporation, Armonk, NY,
USA).
RESULTS
Attentional Bias
We found a significant difference between Stroop RTs on
cocaine words and neutral words, (t[25]¼ 6.87, po0.001),
with cocaine-dependent patients responding slower to
cocaine-related stimuli than to neutral stimuli. This
indicates the presence of an attentional bias. No differences
in accuracy between cocaine and neutral words were found,
(t[25]¼  1.84, ns).
For the imaging data, we did not find significant
activation (po0.05 FWE small volume corrected) for the
cocaine minus neutral words contrast in any of the ROIs
within the patient sample.
Predictors of Recent Cocaine Use
The stepwise regression yielded that two predictors—
craving in the week before treatment and attentional bias-
related activity in the right dACC—met the selection
criterion for inclusion in the model. Other self-report,
behavioral, and imaging variables were excluded based on
the criterion (see Table 3a). Model statistics are displayed in
Table 3b. The first step, including craving in the week
before treatment, accounted for 23% of explained variance
in recent cocaine use. Individual differences in brain
activation for the attentional bias contrast in the right
dACC added another 22% explained variance to the model.
Thus, together both predictors accounted for 45% of
explained variance in the prediction of recent cocaine use.
Bootstrapping confirmed that both individual predictors
were robust predictors of treatment outcome (see Table 3c).
The coefficients indicated a positive association between the
predictors and the outcome measure. These findings
showed that higher self-reported past-week craving and
enhanced activation for cocaine words vs neutral words in
the right dACC (both measured during the first week of
treatment) were associated with more days of recent cocaine
use (measured at 3-month follow-up). Direct associations
between each significant predictor and recent cocaine use
are displayed in Figure 2.
Finally, collinearity statistics indicated that the predictors
were not associated with each other (tolerance¼ 0.98).
Table 2 Mean Reaction Times (milliseconds) and Accuracy
Scores (percentages) for the Stroop Task
Mean SD
RT cocaine words 972 137
RT neutral words 886 126
Accuracy cocaine words 91 8
Accuracy neutral words 93 8
Abbreviation: RT, reaction time.
Table 3a Statistics of Predictor Variables Added in the Stepwise
Regression Analysis
Predictor variables Standardized
coefficients (¼b)
t statistic p-Value
Self-reports
Total years of cocaine use 0.14 0.88 0.387
Number of days of cocaine use in
30 days before treatment entry
0.04 0.22 0.831
Cocaine administration route
Snorting vs smoking 0.18 1.09 0.287
Snorting vs intravenous 0.08 0.46 0.647
Craving in the week before
treatment
0.41 2.57 0.017a
Behavior
Stroop effect RT  0.24  1.51 0.145
Stroop effect accuracy  0.11  0.66 0.519
Imagingb
l-dACC  0.53  1.70 0.104
r-dACC 0.47 3.00 0.006a
l-DLPFC  0.35  1.39 0.178
r-DLPFC  0.27  1.01 0.322
l-insula  0.36  1.41 0.174
r-insula  0.06 0.21 0.832
l-nucleus accumbens  0.11  0.40 0.694
r-nucleus accumbens  0.05  0.17 0.868
l-amygdala  0.37  1.53 0.140
r-amygdala 0.04 0.15 0.884
Abbreviations: RT, reaction time; l, left; r, right; dACC, dorsal anterior cingulate
cortex; DLPFC, dorsolateral prefrontal cortex.
aMeet selection criteria Fenter: pp0.05 and Fremove: pX0.10.
bAttentional bias contrast (cocaine minus neutral).
Table 3b Model Statistics and Change Statistics of the Final Model
Predicting Recent Cocaine Use
Predictor
variables
Model statistics Change statistics
R2 F
Statistic
p-
Value
DR2 DF
statistic
Dp-
Value
Step 1 0.23 7.15 0.013
Craving in the week before treatment
Step 2 0.45 9.26 0.001 0.22 9.00 0.006
r-dACCa
Abbreviations: dACC, dorsal anterior cingulate cortex; r, right.
aAttentional bias contrast (cocaine minus neutral).
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DISCUSSION
The present study is the first to examine to what extent
attentional bias-related brain activity predicts recent
cocaine use after treatment, over and above other relevant
predictors such as craving, substance use severity, and
behavioral measures of attentional bias. We found that both
higher levels of self-reported craving in the week before
treatment and enhanced attentional bias-related brain
activity in the right dACC—measured in the first week of
detoxification treatment—were associated with cocaine use
at 3-month follow-up. Cocaine use severity, behavioral
measures of attentional bias, and other brain regions that
have previously been shown to be associated with atten-
tional bias (ie, DLPFC, insula, nucleus accumbens, and
amygdala) were not significantly associated with cocaine
use at 3-month follow-up. In addition, we found that when
controlling for self-reported craving, individual differences
in right dACC activity made a rather large and unique
contribution to the prediction of recent cocaine use. These
findings suggest that a neural correlate of attentional bias in
the dACC might be a useful biomarker of cocaine use after
treatment. Most importantly, as early as in the first week of
treatment our findings provide information on an indivi-
dual’s risk to use cocaine again 3 months after treatment.
The dorsal part of the ACC has been implicated in
cognitive processes such as salience detection (Seeley et al,
2007), conflict monitoring in general (Botvinick et al, 2004;
Kerns et al, 2004; Egner et al, 2008) and in the presence of
emotionally salient distractors (specifically the right dACC;
Haas et al, 2006). Hyperactivity in the ACC associated with
attentional bias to substance-related cues has previously
been shown in smokers (Luijten et al, 2011, 2012; Nestor
et al, 2011; Janes et al, 2010b) and alcohol-dependent
patients (Vollsta¨dt-Klein et al, 2012), and is thought to
reflect enhanced conflict when task performance is being
interfered by the automatic detection of salient substance-
related stimuli. However, the present design does not rule
out alternative interpretations of the dACC involvement.
For example, it might be possible that dACC activity is
related to the greater requirement for cognitive control
during the drug trials, rather than the content of the stimuli
per se.
In relation to relapse, it is suggested that individual
variations in the brain’s ability to control cognitive conflict
may account for differences in risk of relapse (Garavan and
Hester, 2007). Our results support this idea by finding that
when more top-down control is necessary (ie, increased
dACC activity) to focus on a cognitive task in the presence
of distracting drug cues one is more vulnerable to use
cocaine after treatment. Additionally, individuals who need
less top-down control (as reflected by less to no attentional
bias-related dACC activity) are less susceptible to return to
daily use of cocaine. This is in line with findings of Janes
et al (2010b) who found that attentional bias-related dACC
activity was predictive of relapse in smokers.
Concerning the self-report measures we examined in the
current study, we found that self-reported craving in the
week before treatment—but not substance use severity—
was predictive of cocaine use at 3-month follow-up. Craving
constitutes a central role in established theories of addiction
(Robinson and Berridge, 1993). Indeed several studies have
reported that subjective craving is associated with relapse
and treatment outcome in cocaine-dependent patients
(Weiss et al, 2003; Paliwal et al, 2008; Preston et al, 2009).
More recent models of addiction propose a role for both
craving and attentional bias in the maintenance of
substance use and relapse (Franken, 2003; Field and Cox,
2008). Our results support this by finding that both self-
reported craving in the week before treatment and
individual variability in dACC activity related to attentional
bias were associated with cocaine use at follow-up,
suggesting a role for both processes in relapse. However,
these models suggest that attentional bias predicts relapse
via craving and not directly, whereas our results showed
that dACC activity was a strong predictor, even when
controlling for self-reported craving. This suggests that
enhanced attentional bias-related brain activity might be
independently associated with drug relapse.
Somewhat unexpected in the light of the recent discussion
on the relation between craving and attentional bias (Field,
Table 3c Bootstrap Results for Individual Predictors in the Final
Model Predicting Recent Cocaine Use
Predictor
variables
Unstandardized
coefficients (¼b)
Standard
error
(¼SE)
Bootstrapped 95%
confidence interval
Craving in the week
before treatment
3.82 1.48 1.48–7.36a
r-dACCb 15.62 5.35 4.61–25.14a
Abbreviations: r, right; dACC, dorsal anterior cingulate cortex.
aSignificant (value 0 is not in the confidence interval).
bAttentional bias contrast (cocaine minus neutral).
Figure 2 Correlation between (a) craving in the week before treatment and recent cocaine use and (b) attentional bias-related activation in the right
dACC and recent cocaine use. dACC, dorsal anterior cingulate cortex.
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Munafo and Franken, 2009), no significant correlations
between craving, attentional bias, and dACC activation were
observed (see Supplementary Information, Part II for
results). The meta-analysis by Field et al (2009) showed
that subjective craving is consistently (though weakly)
correlated with behavioral and EEG indices of attentional
bias. Concerning the behavioral measures, it is possible that
the statistical power of the present study was too low to
yield significant results given the fact that the correlations
between craving and the Stroop task are known to be weak
(r¼ 0.15). In addition, dACC activation was not found to be
associated with craving nor behavioral attentional bias. This
is somewhat unexpected since all measures could be
regarded as measures of the same underlying processing:
‘motivational salience’. Although exact interpretation is not
straightforward (also given the relative small n), it seems
at least to be an indication that the ACC does not
necessarily be the neurobiological structure responsible
for cocaine craving. Further, it should be kept in mind that
craving was not measured during fMRI scanning but was an
average measure (OCDUS) of the craving in the week before
the fMRI measurement.
The present study indicates that cocaine use after
treatment is better predicted by neuroimaging than
behavioral measures of the addiction Stroop effect. Other
fMRI studies examining neurocognitive predictors of
substance relapse have reported similar results in metham-
phetamine relapse (Paulus et al, 2005) and cocaine relapse
(Brewer et al, 2008; Jia et al, 2011). Although previous
studies have reported an association between attentional
bias on the behavioral level and drug relapse (Marissen
et al, 2006; Carpenter et al, 2006) we could not find any
significant associations between behavioral measures and
cocaine use outcome (see Supplementary Information, Part
III for results). It might be that functional neuroimaging is a
better predictor because it is a more sensitive measure of
individual differences in biased attention to drug cues than
behavioral measures.
Possible clinical implications of our results include the
use of dopaminergic manipulation to reduce attentional
bias-related brain activity (Ersche et al, 2010; Goldstein
et al, 2010; Luijten et al, 2012) or attentional retraining
(Schoenmakers et al, 2010). Patients who are vulnerable to
relapse due to enhanced attentional bias for drug cues
might benefit from such approaches, although these
interventions need further investigation. Future interven-
tion studies using either psychopharmacological interven-
tions or cognitive training may obtain valuable information
by identifying those patients with higher levels of dACC
activity in response to drug cues.
The present study had limitations. First, we only
measured days of cocaine use in the last month of the 3-
month follow-up period. We could not rule out that patients
who reported to have used 0 days in the last month did not
use in the 2 months before follow-up and could therefore
not term them as ‘non-relapsers’. Thus, with the present
design it was not possible to predict relapse (yes vs no)
which makes it difficult to compare the present results with
other fMRI studies on relapse prediction (eg, Janes et al,
2010b; Paulus et al, 2005). However, it has been found that
continuous and dichotomous drug use outcome measures
are strongly related to each other (McKay et al, 2001),
suggesting that the present outcome measure does provide
some information on relapse risk. To examine associations
between study variables and different drug use outcome
measures, future studies should use multiple outcome
measures (eg, time to relapse, relapse vs non-relapse; see
for a discussion also Miller et al, 1996). Second, while we
found an association between enhanced attentional bias-
related brain activity and cocaine use outcome in patients
after treatment, we could not demonstrate an overall within-
group attentional bias effect in the ROIs. The absence of an
overall effect on the attentional bias contrast (cocaine minus
neutral words) is not an unusual finding in cocaine Stroop
fMRI research (Goldstein et al, 2007, 2009, 2010; Moeller
et al, 2012) and may be due to the presence of individual
differences in brain activity related to attentional bias
(Hester and Garavan, 2009), as manifested by the fact that
brain activity was predictive of relapse in a population of
variable relapse risk. We would like to emphasize, however,
that the task did activate regions that are typically expected
to be activated for a Stroop task such as the dACC and the
DLPFC for the neutral and cocaine condition separately (see
Supplementary Figure 1 in Supplementary Information,
Part VI). Third, we did not assess other psychiatric
disorders using a structured interview or questionnaire
and therefore could not examine the influence of these
disorders on cocaine use outcome. Finally, we had a large
number of predictors and a relatively small sample which
could have led to over-fitting of the prediction model.
Therefore, we performed a stepwise regression analysis to
remove all redundant predictors. To reduce the probability
of type II errors, we included variables in a hierarchical
manner based upon previous literature (self-report mea-
sures first, behavior measures second, and neuroimaging
measures third) so that the predictors are evaluated in each
step separately.
In conclusion, the current study showed the clinical
relevance of measuring attentional bias-related activity in
the dACC in cocaine-dependent patients during the starting
phase of treatment. Not only does this provide valuable
information about the neurocognitive mechanisms of
addiction and of addiction treatment processes, these
measures may also help us identifying individuals who are
at risk of relapse into cocaine use after detoxification
treatment. Although direct clinical implications are not very
easy to implement using fMRI methodology, ultimately
findings like these may help to develop clinical profiles
based on neurocognitive measures to design tailor-made
follow-up treatment schedules. Future treatment interven-
tion studies should investigate how this information might
benefit relapse-vulnerable patients.
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